Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lemaitre Vascular (LMAT) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Lemaitre Vascular (LMAT) over the last 16 years, with Q3 2025 value amounting to $2.3 million.

  • Lemaitre Vascular's Capital Expenditures rose 3658.68% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.0 million, marking a year-over-year increase of 1376.47%. This contributed to the annual value of $7.0 million for FY2024, which is 417.07% down from last year.
  • Per Lemaitre Vascular's latest filing, its Capital Expenditures stood at $2.3 million for Q3 2025, which was up 3658.68% from $1.3 million recorded in Q2 2025.
  • In the past 5 years, Lemaitre Vascular's Capital Expenditures ranged from a high of $2.8 million in Q2 2023 and a low of $460000.0 during Q3 2022
  • Its 5-year average for Capital Expenditures is $1.4 million, with a median of $1.4 million in 2024.
  • In the last 5 years, Lemaitre Vascular's Capital Expenditures skyrocketed by 35112.54% in 2021 and then crashed by 7464.17% in 2022.
  • Over the past 5 years, Lemaitre Vascular's Capital Expenditures (Quarter) stood at $606000.0 in 2021, then soared by 107.92% to $1.3 million in 2022, then grew by 1.51% to $1.3 million in 2023, then surged by 59.81% to $2.0 million in 2024, then grew by 11.59% to $2.3 million in 2025.
  • Its Capital Expenditures stands at $2.3 million for Q3 2025, versus $1.3 million for Q2 2025 and $1.4 million for Q1 2025.